AbbVie Inc annual gross profit for fiscal 2025 was $43.0 billion, an increase of 8.9% from $39.4 billion in fiscal 2024. Trailing-twelve-month gross profit is $44.4 billion. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | TTM | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Profit | $44.4B | $43.0B | $39.4B | $33.9B | $40.6B | $38.8B | $30.4B | $25.8B | $25.0B | $21.2B | $19.8B | $18.4B | $15.5B | $14.2B | $13.9B | $12.8B | $11.3B | $10.2B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Gross Profit | $10.8B | $12.1B | $10.5B | $11.1B | $9.3B | $10.7B | $10.2B | $10.3B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ABBV metrics: Revenue · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All ABBV financial statements → Interactive ABBV charts →
About TickerBase · Data methodology & sources